Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Primary and central hypothyroidism

Endocrinology and metabolism · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Hypothermia, reduced consciousness, hypoventilation, bradycardia, hypotension, hypoglycaemia or severe hyponatraemia in suspected hypothyroidism requires emergency endocrine and critical-care support. In central disease, possible cortisol deficiency is immediately dangerous and glucocorticoid treatment must precede thyroid replacement when clinically indicated.

Synopsis

Distinguish thyroid-gland failure from pituitary or hypothalamic disease, replace hormone safely, and protect patients with possible adrenal insufficiency or special physiological needs.

  • Primary hypothyroidism produces raised TSH with low free T4; central hypothyroidism produces low free T4 with TSH that is low, normal or biologically inadequate.
  • Autoimmune thyroiditis, thyroidectomy and radioiodine are frequent primary causes; pituitary tumours, surgery, radiotherapy, apoplexy and infiltrative disease underlie many central cases.
  • Symptoms such as tiredness, weight gain, constipation, dry skin, cold intolerance and cognitive slowing are common but nonspecific, so diagnosis requires credible biochemistry.
  • Levothyroxine is NICE first-line treatment for primary hypothyroidism; routine liothyronine and natural thyroid extract are not recommended.
  • Adults under 65 without cardiovascular disease can usually start near full replacement, while older people and those with cardiac disease need lower initiation and careful titration.
  • Never use TSH to exclude or titrate central hypothyroidism; specialist follow-up uses free T4, clinical response and the status of other pituitary axes.
  • Before treating central hypothyroidism, assess adrenal function and give glucocorticoid cover first if adrenal insufficiency is possible, because levothyroxine can precipitate crisis.
  • Iron, calcium, food, antacids and several gastrointestinal conditions can reduce levothyroxine absorption; structured administration review is more useful than repeated unexplained dose increases.
  • Pregnancy, planned conception, childhood and severe decompensation need rapid specialist pathways rather than ordinary adult titration.

Key red flags

Central endocrine clues

Headache, visual-field symptoms, amenorrhoea, infertility, reduced libido, loss of body hair, post-partum haemorrhage history, polyuria or previous pituitary treatment should shift attention from the thyroid gland to the sellar axis.

Possible adrenal deficiency

Postural hypotension, weight loss, nausea, abdominal pain, hyponatraemia, hypoglycaemia or unexplained eosinophilia in pituitary disease makes cortisol deficiency a priority; pigmentation usually indicates primary rather than central adrenal failure.

Severe decompensation

Altered consciousness with hypothermia, hypoventilation, bradycardia, hypotension and metabolic disturbance suggests myxoedema coma, which may occur without literal coma and needs immediate critical care.

Investigation priorities

01
TSH and free T4First step

Confirm hypothyroidism and locate dysfunction within the axis.

Management branches

Primary diagnosisConfirm and begin replacement

Raised TSH with free T4 below the local reference interval.

  1. Assess severity, pregnancy possibility, cardiovascular disease, previous thyroid intervention, medicines and features of adrenal or pituitary disease before prescribing.
  2. Start levothyroxine using NICE age and cardiac-risk principles, explain consistent administration and separate it from relevant food, iron and calcium exposure.
  3. Review TSH about every three months until stable, adjusting gradually and avoiding suppression; check free T4 as well if symptoms remain unexplained.
Persistent symptomsReassess before alternative hormone

Symptoms continue after TSH normalises on a stable levothyroxine regimen.

  1. Verify the original overt diagnosis, adherence, free T4, and absence of over-replacement, then seek non-thyroid explanations through focused history and examination.
  2. Treat relevant anaemia, sleep disorder, depression, menopause, cardiopulmonary disease or nutritional deficiency rather than using thyroid hormone as nonspecific therapy.
  3. If substantial symptoms persist after optimisation, refer to an endocrinologist; any liothyronine trial should follow current BTA/Society guidance, shared decision-making and specialist monitoring.

Key medicines

Levothyroxine for primary hypothyroidismAdults under 65 without cardiovascular disease: consider 1.6 micrograms/kg once daily, rounded to the nearest 25 micrograms; age 65 or over, or cardiovascular disease: consider 25 to 50 micrograms once daily with titration.Use the current BNF and product information. Start cautiously with ischaemic heart disease, avoid biochemical suppression, review absorption interactions, and arrange urgent specialist adjustment in pregnancy.
Levothyroxine for central hypothyroidismIndividualised once-daily replacement prescribed and titrated by endocrinology using free T4, symptoms, age and cardiac risk rather than a TSH target.Never start before glucocorticoid coverage when cortisol deficiency is possible. TSH may remain low and must not drive dose reduction; pregnancy and panhypopituitarism need specialist plans.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG145 hypothyroidism managementFirst-line replacement, initiation, biochemical follow-up and treatments not routinely recommended.
  • BNF hypothyroidism treatment summaryCurrent prescribing principles and special situations.
  • BNF levothyroxine sodium monographDose, administration, interactions and monitoring cautions.
  • Society for Endocrinology adrenal crisis guidanceEmergency glucocorticoid sequence when cortisol deficiency is suspected.
  • British Thyroid Association professional guidanceUK specialist statements including use of liothyronine in selected cases.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom